Automatic substitution with biosimilars by pharmacies should start next month in Germany – How will it work?
On 16 Aug 2019, the GSAV came into force. This new law also included legislation with the aim to increase the market
Category: News and updates
German Health minister presents new draft of act to stabilise SHI fund finances
In March 2022, Lauterbach shared a non-authorized draft of his reform plans to stabilise the SHI funds finances. However, this draft version
How to bring innovation into German routine clinical practice?
Hello! In this week’s post, I am describing the G-BA’s initiative to promote innovation in the German health care system and clinical
IQWiG methods for RWE collection for products of same active ingredient class
Recently, I have written about RWE collection, that can be mandated by the G-BA as part of their benefit assessment. Now, the
G-BA defines 4 strict requirements on cefiderocol use to protect its “reserve antibiotics” status
Currently, reserve antibiotics are excluded from a benefit assessment by the G-BA. The G-BA decides whether to accept a new antibiotic onto the